Literature DB >> 15798204

Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Claire K Inman1, Na Li, Paul Shore.   

Abstract

The transcription factor Runx2 is essential for the expression of a number of bone-specific genes and is primarily considered a master regulator of bone development. Runx2 is also expressed in mammary epithelial cells, but its role in the mammary gland has not been established. Here we show that Runx2 forms a novel complex with the ubiquitous transcription factor Oct-1 to regulate the expression of the mammary gland-specific gene beta-casein. The Runx2/Oct-1 complex forms on a Runx/octamer element which is highly conserved in casein promoters. Chromatin immunoprecipitation, RNA interference, promoter mutagenesis, and transient expression analyses were used to demonstrate that the Runx2/Oct-1 complex contributes to the transcriptional regulation of the beta-casein gene. Analysis of the complex revealed autoinhibitory domains for DNA binding in both the N-terminal and the C-terminal regions of Runx2. Oct-1 stimulates the recruitment of Runx2 to the beta-casein promoter by interacting with the C-terminal region of Runx2, suggesting that Oct-1 stimulates Runx2 recruitment by relieving the autoinhibition of Runx2 DNA binding. These findings demonstrate that Runx2 collaborates with Oct-1 and contributes to the expression of a mammary gland-specific gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798204      PMCID: PMC1069618          DOI: 10.1128/MCB.25.8.3182-3193.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

Review 1.  Mineral-binding milk proteins and peptides; occurrence, biochemical and technological characteristics.

Authors:  G E Vegarud; T Langsrud; C Svenning
Journal:  Br J Nutr       Date:  2000-11       Impact factor: 3.718

Review 2.  The virtuoso of versatility: POU proteins that flex to fit.

Authors:  K Phillips; B Luisi
Journal:  J Mol Biol       Date:  2000-10-06       Impact factor: 5.469

Review 3.  Role of Cbfa1 in osteoblast differentiation and function.

Authors:  G Karsenty
Journal:  Semin Cell Dev Biol       Date:  2000-10       Impact factor: 7.727

Review 4.  Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia.

Authors:  J J Westendorf; S W Hiebert
Journal:  J Cell Biochem       Date:  1999       Impact factor: 4.429

Review 5.  Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF.

Authors:  Y Ito
Journal:  Genes Cells       Date:  1999-12       Impact factor: 1.891

Review 6.  Mechanisms of transcriptional regulation by Runt domain proteins.

Authors:  J C Wheeler; K Shigesada; J P Gergen; Y Ito
Journal:  Semin Cell Dev Biol       Date:  2000-10       Impact factor: 7.727

Review 7.  Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone.

Authors:  T J Martin; M T Gillespie
Journal:  Trends Endocrinol Metab       Date:  2001 Jan-Feb       Impact factor: 12.015

8.  Constitutive expression and regulation of collagenase-3 in human breast cancer cells.

Authors:  N Selvamurugan; N C Partridge
Journal:  Mol Cell Biol Res Commun       Date:  2000-04

Review 9.  Osteocalcin: the vitamin K-dependent Ca2+-binding protein of bone matrix.

Authors:  P V Hauschka
Journal:  Haemostasis       Date:  1986

10.  Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line.

Authors:  R K Ball; R R Friis; C A Schoenenberger; W Doppler; B Groner
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  21 in total

1.  Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.

Authors:  M Tandon; Z Chen; A H Othman; J Pratap
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

Review 2.  Metastatic bone disease: role of transcription factors and future targets.

Authors:  Jitesh Pratap; Jane B Lian; Gary S Stein
Journal:  Bone       Date:  2010-06-01       Impact factor: 4.398

Review 3.  The epigenetic landscape of mammary gland development and functional differentiation.

Authors:  Monique Rijnkels; Elena Kabotyanski; Mohamad B Montazer-Torbati; C Hue Beauvais; Yegor Vassetzky; Jeffrey M Rosen; Eve Devinoy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-02-17       Impact factor: 2.673

4.  The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.

Authors:  Daniel Mendoza-Villanueva; Wensheng Deng; Cesar Lopez-Camacho; Paul Shore
Journal:  Mol Cancer       Date:  2010-06-30       Impact factor: 27.401

5.  Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.

Authors:  Kakoli Das; David Tai Leong; Anurag Gupta; Liang Shen; Thomas Putti; Gary S Stein; Andre J van Wijnen; Manuel Salto-Tellez
Journal:  Eur J Cancer       Date:  2009-07-24       Impact factor: 9.162

6.  Buffalo alpha S1-casein gene 5'-flanking region and its interspecies comparison.

Authors:  Amrutlal K Patel; Mahavir Singh; V V S Suryanarayana
Journal:  J Appl Genet       Date:  2013-10-19       Impact factor: 3.240

7.  Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins.

Authors:  Caixia Hou; Abhisek Mandal; Jürgen Rohr; Oleg V Tsodikov
Journal:  Structure       Date:  2020-12-03       Impact factor: 5.006

8.  Hairless is a cofactor for Runt-dependent transcriptional regulation.

Authors:  Pegine B Walrad; Saiyu Hang; J Peter Gergen
Journal:  Mol Biol Cell       Date:  2011-02-16       Impact factor: 4.138

9.  Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.

Authors:  Daniel Mendoza-Villanueva; Leo Zeef; Paul Shore
Journal:  Breast Cancer Res       Date:  2011-10-27       Impact factor: 6.466

10.  Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility.

Authors:  David T Leong; Joleen Lim; Xuewei Goh; Jitesh Pratap; Barry P Pereira; Hui Si Kwok; Saminathan Suresh Nathan; Jason R Dobson; Jane B Lian; Yoshiaki Ito; P Mathijs Voorhoeve; Gary S Stein; Manuel Salto-Tellez; Simon M Cool; Andre J van Wijnen
Journal:  Breast Cancer Res       Date:  2010-10-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.